Do institutional investors and auditors have different standards of due
diligence? 
Well-meaning investment advisers recommend ticking a long checklist
before venturing to trade. A basic requirement is consistent growth in revenues
and profit. Corporate actions such as dividends, bonus and stock-splits come
next. Growth plans and capital expenditure, too, are important. Presence of
foreign investors and mutual funds offer comfort. Valuations tell a story, either of sluggish earnings growth not keeping pace with price gains or yet not reflecting the potential. At
the tail-end is corporate governance. Unable to pin a definition, the
explanation ranges from timely release of quarterly results and holding AGMs to
having independent directors on board as per regulations. With the exercise done
with, the attention shifts to stock-picking. The preference is for high-growth mid
and small caps due to the messaging that large caps are reliable but slow in appreciating. Amid the unrealistic discounting of the mid-cap and small-cap
indices, some stocks stand out. Trading at an attractive P/E of 20 based on trailing
12-month ended December 2017 earnings compared with the hefty valuations of the
BSE Mid-cap index, this particular scrip reported CAGR of 24% in sales and 28%
in profit after tax in the five years till FY 2017. The dividends in the range of 7% and 10%, with FY 2017 seeing no payout, no doubt disappoint but are in line with a company undertaking expansion to grow: Rs 100 crore are being tapped from internal accruals for Rs 600-crore
expansion to add a fifth plant. Importantly, finicky foreign
institutional investors held a huge 39% stake. Mutual funds owned a reassuring
12% equity end March 2018.
External factors, too, are favorable. A scorching summer is set to be
followed by a normal monsoon, thereby boosting the prospects of consumption-based
sectors such as FMCG in which the company operates. Despite the alluring factors, there is a hitch. The auditor has refused to sign the accounts for FY
2018. In fact, the firm has quit, citing lack of access to material
information. The dilemma for investors is if the halving of the stock price
from its September 2017 peak following a 1:1 bonus issue opens a window to take
a bite of the lucrative business of mango-flavored drinks or a warning to stay
away due to a corporate governance issues. 
Manpasand Beverages smashes all conventional theories of investing. Since
debuting in the primary market, the reliance of the net debt-free company considering
cash in hand is on equity for capital expenditure, indicating the confidence of the
promoters in servicing the enhanced base. Yet, there were warning signs. Retail participation in the 40% over-subscription of the IPO was marginal.The
shares listed nearly 11% below the offer price. Operating profit more than
doubled in the year after listing but could expand only about 20% in the next
year.  After mopping up Rs 422 crore in
the run-up to listing in July 2015, a slightly higher amount was collected from
institutional investors a couple of years later to set up bottling plants at
two existing locations and another in a new geography. 
As the outcome of the examination of the books by a new
auditor is awaited, the episode triggers memory of another case of breach of
trust. Welspun India, the largest supplier to the US and the second largest producer
of towels and bed sheets in the world, has lost 60% of its market value since
its high end March 2015 after a prominent US retailer, among the top five
customers, terminated its relationship, accusing the company in August 2016 of wrongly selling Egyptian cotton bed sheets. Target refunded all customers who bought
these sheets over two years. Walmart followed, though it did not cut off ties.
Others such as Bed Bath & Beyond and JC Penney, too, launched probes. Two
class-action suits have been filed. The bath and bed linen maker exports nearly
all its produce, with the US comprising a major chunk, followed by Europe.
Operating profit that had doubled in the previous three years rose about 12% in
FY 2017. The 80% jump in other income seemed to have restricted the fall in the
bottom line to half. Dividend plunged from 100% to a measly 3%. Though net
profit crashed more than 40% in Q3 of FY 2018, institutional investors have not
given up. FIIs controlled about 9% and mutual funds 6% stake end March 2018. The
trailing 12-month negative return has disappeared since the past month. The
consultancy firm hired to examine the issue is yet to submit its report. In the
meantime investors are left to speculate if the market’s impatience to seek
growth year after year prompts companies to seek shortcuts. Besides, the
divergence in the due diligence between institutional investors and the
auditors is a puzzle that needs to be solved.     
j